---

Subhash Kapre

Chief Executive Officer, Inventprise

Subhash established Inventprise in 2012 with the aim of developing cheaper, safer vaccines. A previous board member of the Serum Institute of India, he has over 44 years of experience in research and development. Under a project grant from the Bill & Melinda Gates Foundation, Inventprise has created a liquid heat-stable Rota virus vaccine that can withstand temperatures of 50°C for 5 months.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018